317
Views
12
CrossRef citations to date
0
Altmetric
Original Research

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis

, ORCID Icon, , , , ORCID Icon, , , ORCID Icon, & show all
Pages 2827-2836 | Published online: 06 Nov 2020

References

  • JanciauskieneSM, BalsR, KoczullaR, VogelmeierC, KohnleinT, WelteT. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129–1139.21367592
  • European RS, American Thoracic Society. American thoracic society/European respiratory society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900.14522813
  • BrantlyML, PaulLD, MillerBH, FalkRT, WuM, CrystalRG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis. 1988;138(2):327–336. doi:10.1164/ajrccm/138.2.3273264124
  • StollerJK, BrantlyM. The challenge of detecting alpha-1 antitrypsin deficiency. Copd. 2013;10(Suppl 1):26–34.23527684
  • StollerJK, SmithP, YangP, SprayJ. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med. 1994;61(6):461–467. doi:10.3949/ccjm.61.6.4617828337
  • SilvermanEK, SandhausRA. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360(26):2749–2757. doi:10.1056/NEJMcp090044919553648
  • SiriD, FarahH, HogarthDK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013;111(6):458–464.24267358
  • StockleyRA. The multiple facets of alpha-1-antitrypsin. Ann Transl Med. 2015;3(10):130.26207223
  • CottinV, NunesH, BrilletPY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–593. doi:10.1183/09031936.05.0002100516204587
  • EdenE. Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis. COPD. 2010;7(5):366–374. doi:10.3109/15412555.2010.51015920854052
  • McGeeD, SchwarzL, McClureR, et al. Is PiSS alpha-1 antitrypsin deficiency associated with disease? Pulm Med. 2010;2010:570679. doi:10.1155/2010/57067921687342
  • van VeenIH, Ten BrinkeA, van der LindenAC, RabeKF, BelEH. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med. 2006;100(9):1534–1539.16476537
  • DavilaI, ValeroA, EntrenasLM, ValvenyN, HerraezL. Relationship between serum total IgE and disease severity in patients with allergic asthma in Spain. J Investig Allergol Clin Immunol. 2015;25(2):120–127.
  • DemeoDL, SandhausRA, BarkerAF, et al. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax. 2007;62(9):806–813. doi:10.1136/thx.2006.07584617389752
  • DowsonLJ, GuestPJ, StockleyRA. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1805–1809. doi:10.1164/ajrccm.164.10.210603611734427
  • MiravitllesM, DirksenA, FerrarottiI, et al. European respiratory society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017;50(5):1700610. doi:10.1183/13993003.00610-201729191952
  • ParrDG, GuestPG, ReynoldsJH, DowsonLJ, StockleyRA. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176(12):1215–1221.17872489
  • GuestPJ, HansellDM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol. 1992;45(4):260–266. doi:10.1016/S0009-9260(05)80011-X1395384
  • CuvelierA, MuirJF, HellotMF, et al. Distribution of α1-antitrypsin alleles in patients with bronchiectasis. Chest. 2000;117(2):415–419. doi:10.1378/chest.117.2.41510669684
  • BarnesPJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183–192. doi:10.1038/nri225418274560
  • ChalmersJD, MoffittKL, Suarez-CuartinG, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017;195(10):1384–1393. doi:10.1164/rccm.201605-1027OC27911604
  • TurinoGM, MaS, CantorJO, LinYY. Biomarkers in alpha-1 antitrypsin deficiency chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(Suppl 4):S336–340. doi:10.1513/AnnalsATS.201509-574KV27564670
  • GreulichT, NellC, HerrC, et al. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003–2015. Orphanet J Rare Dis. 2016;11(1):75. doi:10.1186/s13023-016-0453-827282198
  • VeithM, KlemmerA, AntonI, et al. Diagnosing alpha-1-antitrypsin deficiency using A PCR/luminescence-based technology. Int J Chron Obstruct Pulmon Dis. 2019;14:2535–2542. doi:10.2147/COPD.S22422131819391
  • HulsenT, de VliegJ, AlkemaW. BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9(1):488. doi:10.1186/1471-2164-9-48818925949
  • StrnadP, McElvaneyNG, LomasDA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–1455. doi:10.1056/NEJMra191023432268028
  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582.28128970
  • GeldmacherH, BillerH, HerbstA, et al. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Dtsch Med Wochenschr. 2008;133(50):2609–2614. doi:10.1055/s-0028-110585819052996
  • BuistAS, McBurnieMA, VollmerWM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-417765523
  • RingshausenFC, de RouxA, DielR, HohmannD, WelteT, RademacherJ. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46(6):1805–1807. doi:10.1183/13993003.00954-201526293498
  • ChalmersJD, AlibertiS, PolverinoE, et al. The EMBARC European bronchiectasis registry: protocol for an international observational study. ERJ Open Res. 2016;2(1):00081–2015. doi:10.1183/23120541.00081-201527730179
  • CarretoL, MorrisonM, DonovanJ, et al. Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis. Thorax. 2020. doi:10.1136/thoraxjnl-2019-214195
  • RahaghiFF, SandhausRA, BrantlyML, et al. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD. 2012;9(4):352–358. doi:10.3109/15412555.2012.66943322506682
  • ChaiCS, LiamCK, PangYK, et al. Clinical phenotypes of COPD and health-related quality of life: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2019;14:565–573. doi:10.2147/COPD.S19610930880946
  • ErikssonS. A 30-year perspective on α1-antitrypsin deficiency. Chest. 1996;110(6 Suppl):237S–242S. doi:10.1378/chest.110.6_Supplement.237S8989157
  • ParrDG, StoelBC, StolkJ, StockleyRA. Pattern of emphysema distribution in α1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med. 2004;170(11):1172–1178. doi:10.1164/rccm.200406-761OC15306534